Last reviewed · How we verify
NCT04692597
Low Level Laser Therapy (LLLT) for the Treatment of Hand Osteoarthritis.
NA trial testing Phoenix Thera-Lase System in Low Level Laser Therapy in 83 participants. Terminated before completion.
9 December 2025
Quick facts
| Lead sponsor | David Moss |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 83 |
| Start date | 2 March 2021 |
| Primary completion | 9 December 2025 |
| Estimated completion | 9 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Phoenix Thera-Lase System
- SHAM Phoenix Thera-Lase System
Conditions studied
- Low Level Laser Therapy — all drugs for Low Level Laser Therapy →
- Osteoarthritis — all drugs for Osteoarthritis →
- Family Medicine — all drugs for Family Medicine →
- Pain Management — all drugs for Pain Management →
Sponsor
David Moss
Who can join
18 and older, any sex, with Low Level Laser Therapy or Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomized, control trial of Active Duty and DoD Beneficiaries, age 18 years or older, with complaints of hand osteoarthritis. Subjects will be randomized into one of two groups receiving either LLLT or sham LLLT. Subjects will receive LLLT or sham LLLT weekly over a period of six weeks. At each visit, patients will rate their pain using the Defense and Veterans Pain Rating Scale (DVPRS) and assess their functionality using the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire. Subjects will have a follow up visit six weeks after the treatment protocol for a final assessment of pain and function. The Phoenix Thera-Lase laser is a Class II, 510k cleared device (#K151521) and is legally marketed in the US. Investigators are using in accordance with its approved labeling and no changes to the approved labeling are being sought.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04692597
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Low Level Laser Therapy
Currently open trials in the same condition.
- NCT07381361 — Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment · NA · active not recruiting
- NCT06986629 — Effect of Photobiostimulation Versus Pulsed Electromagnetic Field on Quality of Life in Adults With Chronic Rhinosinusit · NA · recruiting
- NCT07190950 — Effects of Low-level Laser Therapy on Soft and Hard Tissue Healing After Impacted Mandibular Third Molar Extraction · NA · recruiting
Other David Moss trials
Trials by the same sponsor.
- NCT04529070 — Nightmare Rescripting and Rehearsal · NA · terminated
- NCT04236908 — Accessible Acupuncture for the Warrior With Acute Low Back Pain · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04692597 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by David Moss
- Last refreshed: 16 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04692597.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing